Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia

Completed

Conditions studied: Central Centrifugal Scarring Alopecia, Lichen Planopilaris, Discoid Lupus Erythematosus

In brief

The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.

Key facts

Study ID

NCT00691769

Run by

Wake Forest University

People needed

8

Starts

2006-04-26

Expected to finish

2012-11-26

Last updated by the study team

2018-07-06

Who can join

Age: 30 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Participants ages 30 years or older with a biopsy- proven diagnosis of CCSA.
• Undergone standard of care treatment for CCSA by a WFUSM Dermatologist
• Women of child bearing age will be required to have a negative pregnancy test in order to participate in the study
• Participants ages 30 years or older with a biopsy- proven diagnosis of LP.
• Participants ages 30 years or older with a biopsy- proven diagnosis of DLE.
• Healthy participants must be ages 30 years or older.

You may not qualify if…

• Age less than 30 years of age.
• Clinically evident bacterial or viral infection of the scalp.
• Pregnant or nursing woman of child-bearing potential.
• Participation in any other investigative research study involving study medication.
• Inability to return for the biopsy visit.

Where it is running

• Wake Forest University Health Sciences Dermatology — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.